Therapeutic Utility of Bacteriophage in Bovine Mastitis

Shende, Rajesh Kumar; Hirpurkar, Sadanand Devidas; Sannat, Chandrahas

doi:10.5455/ijlr.20170707051745

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In mouse mastitis models, phages have been reported to intramammarily reduce the number of propagating pathogens [24][25][26][27]. A study that treated asymptomatic mastitis in cows infected with S. aureus using Staphylococcus phage K reported a 16.7% cure rate (3 of 18 quarters) [28], whereas another study reported a cure rate of 66.66% (4 of 6 cases) when a phage cocktail consisting of Bacillus-and Escherichia-specific phages was applied to symptomatic mastitis cows [29]. The use of phages to treat mastitis is not straightforward due to proteases produced by the innate immune system and lipid and protein contents of raw milk that prevent phages from attaching to host cells [30].…”

Section: Introductionmentioning

confidence: 99%

Isolation of bacteriophages specific to bovine mastitis-causing bacteria and characterization of their lytic activity in pasteurized milk

Imklin,

Patikae,

Poomirut

et al. 2024

Vet World

View full text Add to dashboard Cite

Background and Aim: Bovine mastitis is one of the most serious issues in dairy production. It is caused by contagious and coliform pathogens such as Staphylococcus spp., Escherichia coli, and Klebsiella pneumoniae. In addition, the emergence of drug-resistant bacteria raises urgent concerns in the field of drug treatment, thus requiring the exploration of alternative treatments. Bacteriophage therapy has been shown to be a promising alternative approach for the control of antibiotic-resistant pathogens. In this study, we aimed to isolate phages specific to contagious mastitis and coliform mastitis, characterize the isolated phages, and examine their ability to lyse bacteria in pasteurized milk samples. Materials and Methods: The Staphylococcus phage vB_Sau-RP15 isolated from raw milk in our previous study was used in this study. Other three phages, vB_Eco-RN12i1, vB_Kpn-RN14i1, and vB_Ssc-RN20i3, were isolated from wastewater using E. coli 5823, K. pneumoniae 194, and Staphylococcus sciuri MM01 as hosts, respectively. The host range and efficiency of plating (EOP) were determined following phage isolation. Moreover, the lysis activities of these phages against their hosts were investigated in pasteurized milk using a multiplicity of infections (MOIs) of 10 and 100 at 37°C. Phages were applied using individual and combination phages. Results: According to the EOP results, all phages showed high specificity to their respective hosts. They are tailed phages with distinct morphologies. Individual phage treatments in spiked pasteurized milk with their respective bacterial hosts significantly reduced the bacterial counts in both MOI conditions during the first 2 h of the treatment (approximately 1–8 log reduction compared to the control). Although these phages specifically infected only their hosts, the phage cocktail resulted in a better result compared to the use of individual phage. However, bacterial regrowth was observed in all experiments, which may be related to the development of phage-insensitive mutants. Conclusion: Our findings suggest that the application of phages could be used to treat bovine mastitis. Phage cocktail is suitable to promote the efficacy of phage treatment in pasteurized milk. However, when considering the use of phages in dairy cows, certain phage properties in raw milk and in vivo and ex vivo should be highlighted to ensure their effectiveness as biocontrol agents for bovine mastitis treatment. Keywords: bovine, Escherichia coli, Klebsiella pneumoniae, mastitis, phage, Staphylococcus.

show abstract